Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076.SS)
CNY 51.9
(0.31%)
CNY 51.9
(0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.02 Billion | 651.29 Million | 643.86 Million | 566.87 Million | 371.53 Million | 255.52 Million |
| Cost of Revenue | 403.39 Million | 276.32 Million | 284.87 Million | 237.15 Million | 173.25 Million | 101.99 Million |
| Gross Profit | 622.95 Million | 374.97 Million | 358.99 Million | 329.71 Million | 198.27 Million | 153.53 Million |
| Operating Expenses | 399.61 Million | 255.53 Million | 214.14 Million | 159.5 Million | 136.28 Million | 111.99 Million |
| Selling, General and Administrative Expenses | 273.33 Million | 88.1 Million | 70.84 Million | 51.33 Million | 37.96 Million | 22.85 Million |
| Research and Development Expenses | 124.88 Million | 69.47 Million | 63.08 Million | 60.53 Million | 46.49 Million | 35.12 Million |
| Other Expenses | 1.38 Million | 97.95 Million | 80.21 Million | 47.63 Million | 51.82 Million | -95.19 Thousand |
| Cost and Expenses | 843.88 Million | 531.86 Million | 499.01 Million | 396.66 Million | 309.54 Million | 213.98 Million |
| Operating Income | 189.66 Million | 124.85 Million | 128.31 Million | 143.81 Million | 67.8 Million | 31.43 Million |
| Interest Expense | 16.08 Million | 9.26 Million | 6.11 Million | 11.63 Million | 7.16 Million | 9.38 Million |
| Income Tax Expense | 7.67 Million | 387.7 Thousand | 16.92 Million | 26.53 Million | 8.6 Million | -13.34 Million |
| Earnings before Tax | 173.12 Million | 123.15 Million | 125.73 Million | 146.56 Million | 53.41 Million | 31.34 Million |
| Net Income | 162.93 Million | 129.1 Million | 115.38 Million | 123.44 Million | 48.61 Million | 43.9 Million |
| Earnings Per Share Basic | 0.76 | 0.61 | 0.54 | 0.58 | 0.23 | 0.32 |
| Earnings Per Share Diluted | 0.76 | 0.61 | 0.54 | 0.58 | 0.23 | 0.32 |
| Weighted Average Shares Outstanding | 214.38 Million | 213.18 Million | 213.18 Million | 213.18 Million | 213.18 Million | 137.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 214.38 Million | 213.18 Million | 213.18 Million | 213.18 Million | 213.18 Million | 137.21 Million |
| Gross Margin | 0.61 | 0.58 | 0.56 | 0.58 | 0.53 | 0.60 |
| EBIT Margin | 0.32 | 0.38 | 0.36 | 0.43 | 0.29 | 0.26 |
| Profit Margin | 0.16 | 0.20 | 0.18 | 0.22 | 0.13 | 0.17 |
| EBITDA | 324.76 Million | 237.28 Million | 221.02 Million | 236.27 Million | 107.59 Million | 60.12 Million |
| Earnings Before Tax Margin | 0.18 | 0.19 | 0.20 | 0.25 | 0.18 | 0.12 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 420.75 Million | 472.32 Million | 355.1 Million | 321.65 Million | 1.02 Billion | 308.68 Million |
| Cost of Revenue | 112.45 Million | 173.93 Million | 116.47 Million | 136.78 Million | 457.06 Million | 108.91 Million |
| Gross Profit | 308.3 Million | 298.39 Million | 238.63 Million | 184.86 Million | 569.28 Million | 199.76 Million |
| Operating Expenses | 153.84 Million | 118.39 Million | 158 Million | 119.91 Million | 385.56 Million | 120.44 Million |
| Selling, General and Administrative Expenses | 183.64 Million | 74.77 Million | 85.61 Million | 75.33 Million | - | 145.49 Million |
| Research and Development Expenses | 60.25 Million | 39.61 Million | 66.24 Million | 32.36 Million | - | 45.54 Million |
| Other Expenses | -90.06 Million | -3.99 Million | -6.14 Million | -12.2 Million | -28.89 Million | 2.83 Million |
| Cost and Expenses | 266.29 Million | 292.32 Million | 274.48 Million | 256.7 Million | 842.62 Million | 229.36 Million |
| Operating Income | 130.51 Million | 180 Million | 80.62 Million | 64.95 Million | 183.72 Million | 66.9 Million |
| Interest Expense | 9.2 Million | 7.53 Million | 6.34 Million | 5.02 Million | 16.08 Million | 4.01 Million |
| Income Tax Expense | 9.34 Million | 9.31 Million | 15.88 Million | -16.83 Million | 7.67 Million | 16.48 Million |
| Earnings before Tax | 128.27 Million | 176.51 Million | 80.45 Million | 58.27 Million | 173.12 Million | 66.97 Million |
| Net Income | 123.08 Million | 160.83 Million | 66.32 Million | 71.22 Million | 162.93 Million | 49.86 Million |
| Earnings Per Share Basic | 0.58 | 0.75 | 0.31 | 0.33 | - | 0.23 |
| Earnings Per Share Diluted | 0.56 | 0.70 | 0.31 | 0.33 | - | 0.23 |
| Weighted Average Shares Outstanding | 212.21 Million | 214.76 Million | 213.18 Million | 213.18 Million | 213.18 Million | 213.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 219.79 Million | 230.13 Million | 213.18 Million | 213.18 Million | 213.18 Million | 213.18 Million |
| Gross Margin | 0.73 | 0.63 | 0.67 | 0.57 | 0.55 | 0.65 |
| EBIT Margin | 0.33 | 0.49 | 0.27 | 0.31 | - | 0.27 |
| Profit Margin | 0.29 | 0.34 | 0.19 | 0.22 | 0.16 | 0.16 |
| EBITDA | 137.48 Million | 230.33 Million | 96.5 Million | 100.77 Million | - | 83.43 Million |
| Earnings Before Tax Margin | 0.31 | 0.38 | 0.23 | 0.20 | 0.18 | 0.22 |
601326
BEDMUTHA
SIEB
SSR
6615
600521